The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Tuning the Cytokine Responses: An Update on Interleukin (IL)-4 and IL-13 Receptor Complexes
Open accessAbstract
Interleukin (IL)-4 and IL-13 are related cytokines that regulate many aspects of allergic inflammation. They play important roles in regulating the responses of lymphocytes, myeloid cells, and non-hematopoietic cells. In T-cells, IL-4 induces the differentiation of naïve CD4 T cells into Th2 cells, in B cells, IL-4 drives the immunoglobulin (Ig) class switch to IgG1 and IgE, and in macrophages, IL-4 and IL-13 induce alternative macrophage activation. This review gives a short insight into the functional formation of these cytokine receptors. I will discuss both the binding kinetics of ligand/receptor interactions and the expression of the receptor chains for these cytokines in various cell types; both of which are crucial factors in explaining the efficiency by which these cytokines induce intracellular signaling and gene expression. Work initiated in part by William (Bill) E. Paul on IL-4 some 30 years ago has now grown into a major building block of our current understanding of basic immunology and the immune response. This knowledge on IL-4 has growing clinical importance, as therapeutic approaches targeting the cytokine and its signal transduction are becoming a part of the clinical practice in treating allergic diseases. Just by reading the reference list of this short review, one can appreciate the enormous input Bill has had on shaping our understanding of the pathophysiology of allergic inflammation and in particular the role of IL-4 in this process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J.-I., Ohtani, M., Fujii, H., & Koyasu, S. (2010) · Nature · doi:10.1038/nature08636 · Cited by 1,992
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 1,938
The IL-4 receptor: signaling mechanisms and biologic functions
Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., & Paul, W. E. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.701 · Cited by 1,545
Fichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R. K., & Kitani, A. (2006) · Nature Medicine · doi:10.1038/nm1332 · Cited by 889
Yoshimoto, T., & Paul, W. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1285 · Cited by 841
Activated Type 2 Innate Lymphoid Cells Regulate Beige Fat Biogenesis
Lee, M.-W., Odegaard, J. I., Mukundan, L., Qiu, Y., Molofsky, A. B., Nussbaum, J. C., Yun, K., Locksley, R. M., & Chawla, A. (2015) · Cell · doi:10.1016/j.cell.2014.12.011 · Cited by 677
REGULATION OF TH2 DIFFERENTIATION AND Il4 LOCUS ACCESSIBILITY
Ansel, K. M., Djuretic, I., Tanasa, B., & Rao, A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115821 · Cited by 645
IL25 elicits a multipotent progenitor cell population that promotes TH2 cytokine responses
Saenz, S. A., Siracusa, M. C., Perrigoue, J. G., Spencer, S. P., Urban Jr, J. F., Tocker, J. E., Budelsky, A. L., Kleinschek, M. A., Kastelein, R. A., Kambayashi, T., et al. (2010) · Nature · doi:10.1038/nature08901 · Cited by 555
IL-4 in the brain: a cytokine to remember
Gadani, S. P., Cronk, J. C., Norris, G. T., & Kipnis, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202246 · Cited by 549
Molecular and Structural Basis of Cytokine Receptor Pleiotropy in the Interleukin-4/13 System
LaPorte, S. L., Juo, Z. S., Vaclavikova, J., Colf, L. A., Qi, X., Heller, N. M., Keegan, A. D., & Garcia, K. C. (2008) · Cell · doi:10.1016/j.cell.2007.12.030 · Cited by 517
Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis
Mchedlidze, T., Waldner, M., Zopf, S., Walker, J., Rankin, A. L., Schuchmann, M., Voehringer, D., McKenzie, A. N. J., Neurath, M. F., Pflanz, S., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.018 · Cited by 502
Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin
Pandey, A., Ozaki, K., Baumann, H., Levin, S. D., Puel, A., Farr, A. G., Ziegler, S. F., Leonard, W. J., & Lodish, H. F. (2000) · Nature Immunology · doi:10.1038/76923 · Cited by 445
Cloning of the Murine Thymic Stromal Lymphopoietin (Tslp) Receptor
Park, L. S., Martin, U., Garka, K., Gliniak, B., Di Santo, J. P., Muller, W., Largaespada, D. A., Copeland, N. G., Jenkins, N. A., Farr, A. G., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.659 · Cited by 415
A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma
Piper, E., Brightling, C., Niven, R., Oh, C., Faggioni, R., Poon, K., She, D., Kell, C., May, R. D., Geba, G. P., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00223411 · Cited by 373
Regulation of inflammation by interleukin-4: a review of "alternatives"
Luzina, I. G., Keegan, A. D., Heller, N. M., Rook, G. A. W., Shea-Donohue, T., & Atamas, S. P. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0412214 · Cited by 351
B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells
Brown, M. A., Pierce, J. H., Watson, C. J., Falco, J., Ihle, J. N., & Paul, W. E. (1987) · Cell · doi:10.1016/0092-8674(87)90339-4 · Cited by 351
Commentary: IL-4 and IL-13 receptors and signaling
McCormick, S. M., & Heller, N. M. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.023 · Cited by 317
The Biology of Thymic Stromal Lymphopoietin (TSLP)
Ziegler, S. F., Roan, F., Bell, B. D., Stoklasek, T. A., Kitajima, M., & Han, H. (2013) · Advances in Pharmacology · doi:10.1016/b978-0-12-404717-4.00004-4 · Cited by 298
Negative regulation of cytokine signaling
Greenhalgh, C. J., & Hilton, D. J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.3.348 · Cited by 258
Seder, R. A., Paul, W. E., Dvorak, A. M., Sharkis, S. J., Kagey-Sobotka, A., Niv, Y., Finkelman, F. D., Barbieri, S. A., Galli, S. J., & Plaut, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2835 · Cited by 258
Enhancer-Mediated Control of Macrophage-Specific Arginase I Expression
Pauleau, A.-L., Rutschman, R., Lang, R., Pernis, A., Watowich, S. S., & Murray, P. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7565 · Cited by 243
Moqbel, R., Ying, S., Barkans, J., Newman, T. M., Kimmitt, P., Wakelin, M., Taborda-Barata, L., Meng, Q., Corrigan, C. J., Durham, S. R., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.4939 · Cited by 218
HART, T. K., BLACKBURN, M. N., BRIGHAM-BURKE, M., DEDE, K., AL-MAHDI, N., ZIA-AMIRHOSSEINI, P., & COOK, R. M. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2002.01973.x · Cited by 201
Polarization of IL-4- and IFN-γ-producing CD4+ T cells following activation of naive CD4+ T cells
Nakamura, T., Kamogawa, Y., Bottomly, K., & Flavell, R. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.3.1085 · Cited by 180
Paul, W. E. (2015) · Cytokine · doi:10.1016/j.cyto.2015.01.038 · Cited by 177
Junttila, I., Mizukami, K., Dickensheets, H. L., Meier‐Schellersheim, M., Yamane, H., Donnelly, R. P., & Paul, W. E. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080452 · Cited by 170
Self-citationType I IL-4Rs Selectively Activate IRS-2 to Induce Target Gene Expression in Macrophages
Heller, N. M., Qi, X., Junttila, I. S., Shirey, K. A., Vogel, S. N., Paul, W. E., & Keegan, A. D. (2008) · Science Signaling · doi:10.1126/scisignal.1164795 · Cited by 162
Self-citationNonaka, M., Nonaka, R., Woolley, K. L., Adelroth, E. C., Miura, K., Okhawara, Y., Glibetić, M., Nakano, K., O’Byrne, P. M., & Dolovich, J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.6.3234 · Cited by 152
Newcomb, D. C., Zhou, W., Moore, M. L., Goleniewska, K., Hershey, G. K. K., Kolls, J. K., & Peebles, R. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803868 · Cited by 126
Controlling cytokine signaling by constitutive inhibitors
Rakesh, K., & Agrawal, D. K. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.042 · Cited by 124
Milner, J. D., Orekov, T., Ward, J. M., Cheng, L., Torres-Velez, F. J., Junttila, I., Sun, G., Buller, M., Morris, S. C., Finkelman, F. D., et al. (2010) · Blood · doi:10.1182/blood-2009-11-255174 · Cited by 115
Self-citationNappo, G., Handle, F., Santer, F. R., McNeill, R. V., Seed, R., Collins, A. T., Morrone, G., Čulig, Z., Maitland, N. J., & Erb, H. H. H. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.23 · Cited by 105
Th2 LCR is essential for regulation of Th2 cytokine genes and for pathogenesis of allergic asthma
Koh, B. H., Hwang, S. S., Kim, J., Lee, W., Kang, M., Lee, C. G., Park, J., Flavell, R. A., & Lee, G. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005383107 · Cited by 103
Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines
Junttila, I., Creusot, R. J., Moraga, I., Bates, D. L., Wong, M. T., Alonso, M. N., Suhoski, M. M., Lupardus, P. J., Meier‐Schellersheim, M., Engleman, E. G., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1096 · Cited by 85
Self-citationMoraga, I., Richter, D., Wilmes, S., Winkelmann, H., Jude, K. M., Thomas, C., Suhoski, M. M., Engleman, E. G., Piehler, J., & García, K. C. (2015) · Science Signaling · doi:10.1126/scisignal.aab2677 · Cited by 67
Structural basis of the proinflammatory signaling complex mediated by TSLP
Verstraete, K., van Schie, L., Vyncke, L., Bloch, Y., Tavernier, J. H., Pauwels, E., Peelman, F., & Savvides, S. N. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2794 · Cited by 59
Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.
Antoniu, S. A. (2010) · PubMed · Cited by 58
A TSLP-complement axis mediates neutrophil killing of methicillin-resistant Staphylococcus aureus
West, E. E., Spolski, R. J., Kazemian, M., Yu, Z., Kemper, C., & Leonard, W. J. (2016) · Science Immunology · doi:10.1126/sciimmunol.aaf8471 · Cited by 55
Sosman, J. A., Kefer, C., Fisher, R. I., Ellis, T. M., & Fisher, S. G. (1994) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058878 · Cited by 50
Dynamics and Interaction of Interleukin-4 Receptor Subunits in Living Cells
Gandhi, H., Worch, R., Kurgonaite, K., Hintersteiner, M., Schwille, P., Bökel, C., & Weidemann, T. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.07.077 · Cited by 50
Hua, F., Ribbing, J., Reinisch, W., Cataldi, F. A., & Martin, S. W. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12589 · Cited by 48
Guo, L., Urban, J. F., Zhu, J., & Paul, W. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3984 · Cited by 43
IL-4Rα Inhibitor for Atopic Disease
Chang, H. Y., & Nadeau, K. C. (2017) · Cell · doi:10.1016/j.cell.2017.06.046 · Cited by 39
Paradoxical Effects of Rapamycin on Experimental House Dust Mite-Induced Asthma
Fredriksson, K., Fielhaber, J. A., Lam, J., Yao, X., Meyer, K. S., Keeran, K. J., Nugent, G. Z., Qu, X., Yu, Z., Moss, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033984 · Cited by 37
Schieck, M., Sharma, V., Michel, S., Toncheva, A. A., Worth, L., Potaczek, D. P., Genuneit, J., Kretschmer, A., Depner, M., Dalphin, J., et al. (2014) · Allergy · doi:10.1111/all.12450 · Cited by 34
Richter, D., Moraga, I., Winkelmann, H., Birkholz, O., Wilmes, S., Schulte, M., Kraich, M., Kenneweg, H., Beutel, O., Selenschik, P., et al. (2017) · Nature Communications · doi:10.1038/ncomms15976 · Cited by 32
Functional epitope of common γ chain for interleukin‐4 binding
Zhang, J.-L., Buehner, M., & Sebald, W. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02796.x · Cited by 31
Cited by
Hellenbrand, D. J., Quinn, C. M., Piper, Z. J., Morehouse, C. N., Fixel, J. A., & Hanna, A. S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02337-2 · Cited by 635
The Human and Mouse Enteric Nervous System at Single-Cell Resolution
Drokhlyansky, E., Smillie, C. S., Van Wittenberghe, N., Ericsson, M., Griffin, G. K., Eraslan, G., Dionne, D., Cuoco, M. S., Goder-Reiser, M. N., Sharova, T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.003 · Cited by 574
Furue, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155382 · Cited by 419
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
Oladunni, F. S., Park, J.-G., Pino, P. A., Gonzalez, O., Akhter, A., Allué-Guardia, A., Olmo-Fontánez, A., Gautam, S., Garcia-Vilanova, A., Ye, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19891-7 · Cited by 402
Kurki, M. I., Karjalainen, J., Palta, P., Sipilä, T. P., Kristiansson, K., Donner, K., Reeve, M. P., Laivuori, H., Aavikko, M., Kaunisto, M. A., et al. (2022) · medRxiv · doi:10.1101/2022.03.03.22271360 · Cited by 397
Metadata
- Authors
- Junttila, I. S.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-06-07
- Volume
- 9
- Pages
- 888-888
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2806376977
- Cited by
- 684
- References
- 50
- FWCI
- 13.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.